• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGilead

Gilead

0
COVID forgotten communities
NewslettersThe communities we forget during COVID-19
By Sy MukherjeeApril 30, 2020
Gilead remdesivir coronavirus FDA
HealthGilead’s remdesivir won’t be a COVID-19 miracle cure, but it’s still an important first step
By Sy MukherjeeApril 30, 2020
HealthGilead says COVID-19 recovery drug hit primary target
By BloombergApril 29, 2020
Gilead coronavirus drug effective in coronavirus patients: report
HealthGilead stock surges on report of coronavirus drug patients ‘seeing rapid recoveries’
By Drew Armstrong and BloombergApril 16, 2020
Gilead coronavirus
NewslettersGilead made a remarkable request of the FDA in regard to its coronavirus drug
By Sy MukherjeeMarch 25, 2020
Coronavirus drug Gilead Washington
HealthGilead’s coronavirus treatment is already being used in Washington state
By Sy MukherjeeMarch 10, 2020
Gilead coronavirus trial
NewslettersCan Gilead tame the coronavirus?
By Sy MukherjeeFebruary 27, 2020
Gilead remdesivir clinical trials
HealthGilead’s coronavirus treatment is barreling its way into new clinical trials
By Sy MukherjeeFebruary 26, 2020
COVID-19-Coronavirus-microscope
HealthThe first U.S. trial for a coronavirus treatment has started
By Sy MukherjeeFebruary 25, 2020
Coronavirus vaccine development
HealthThe first coronavirus drug candidate is set for testing in China
By Sy MukherjeeFebruary 3, 2020
Biotech IPO Allogene
HealthWhy Cancer Biotech Allogene Just Scored an Eye Popping $324 Million IPO
By Sy MukherjeeOctober 11, 2018
The American Enterprise Institute photo of Scott Gottlieb
HealthThe FDA Is Naming and Shaming Companies Accused of Blocking Cheap Generic Drugs
By Sy MukherjeeMay 17, 2018
Hepatitis C drug can cure, if patients can get it
HealthHepatitis C Drugs Can Cost $84,000. This New One May Be Just As Good—But Cost $300
By Sy MukherjeeApril 12, 2018
A picture taken on May 11, 2012 in a pha
HealthNew Zealand Is About to Make the Revolutionary HIV Prevention Drug Truvada Almost Free
By Sy MukherjeeFebruary 7, 2018
Inside The Nasdaq MarketSite As Juno Therapeutics Releases IPO
HealthWhy Analysts Are Calling Celgene’s $9 Billion Juno Acquisition a ‘Smart’ Biotech Deal
By Sy MukherjeeJanuary 22, 2018
0
Most Popular
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Investing
Ray Dalio warns the world is ‘on the brink’ of a capital war of weaponizing money—and gold is the best way for people to protect themselvesAn image of a popular article
By Sasha RogelbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.